Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot

Eur Heart J. 2023 Jan 14;44(3):236. doi: 10.1093/eurheartj/ehac601.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acute Coronary Syndrome* / chemically induced
  • Acute Coronary Syndrome* / drug therapy
  • Clopidogrel
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use
  • Ticlopidine / adverse effects

Substances

  • Clopidogrel
  • Platelet Aggregation Inhibitors
  • Ticlopidine